company background image
SLP logo

Simulations Plus NasdaqGS:SLP Stock Report

Last Price

US$30.22

Market Cap

US$604.6m

7D

-5.6%

1Y

-26.9%

Updated

07 Oct, 2024

Data

Company Financials +

Simulations Plus, Inc.

NasdaqGS:SLP Stock Report

Market Cap: US$604.6m

SLP Stock Overview

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

SLP fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Simulations Plus, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Simulations Plus
Historical stock prices
Current Share PriceUS$30.22
52 Week HighUS$51.22
52 Week LowUS$29.95
Beta0.69
11 Month Change-12.41%
3 Month Change-23.63%
1 Year Change-26.92%
33 Year Change-20.05%
5 Year Change-11.43%
Change since IPO2,097.82%

Recent News & Updates

Simulations Plus: Declining Margins Are A Problem

Aug 22

Simulations Plus: Steady Growth, But What About The Margins?

Jul 10

Recent updates

Simulations Plus: Declining Margins Are A Problem

Aug 22

Simulations Plus: Steady Growth, But What About The Margins?

Jul 10

Simulations Plus: Reliance On Consulting And Acquisitions Creates Doubts

May 14

Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price

Mar 29
Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Feb 09
Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Feb 01

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Jan 12
We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Nov 06
Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Sep 06
Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Jun 28
Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Feb 10
Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case

Nov 23
With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case

A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Oct 21
A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Sep 19
Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Simulations Plus goes ex-dividend tomorrow

Jul 21

Simulations Plus Q3 2022 Earnings Preview

Jul 05

Shareholder Returns

SLPUS Healthcare ServicesUS Market
7D-5.6%-2.2%0.1%
1Y-26.9%-2.8%32.2%

Return vs Industry: SLP underperformed the US Healthcare Services industry which returned -2.8% over the past year.

Return vs Market: SLP underperformed the US Market which returned 32.2% over the past year.

Price Volatility

Is SLP's price volatile compared to industry and market?
SLP volatility
SLP Average Weekly Movement4.8%
Healthcare Services Industry Average Movement9.5%
Market Average Movement6.4%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: SLP has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: SLP's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996195Shawn O'Connorwww.simulations-plus.com

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Simulations Plus, Inc. Fundamentals Summary

How do Simulations Plus's earnings and revenue compare to its market cap?
SLP fundamental statistics
Market capUS$604.63m
Earnings (TTM)US$9.65m
Revenue (TTM)US$66.98m

62.7x

P/E Ratio

9.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SLP income statement (TTM)
RevenueUS$66.98m
Cost of RevenueUS$18.40m
Gross ProfitUS$48.58m
Other ExpensesUS$38.93m
EarningsUS$9.65m

Last Reported Earnings

May 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.48
Gross Margin72.53%
Net Profit Margin14.40%
Debt/Equity Ratio0%

How did SLP perform over the long term?

See historical performance and comparison